ArticleBMC cancer2025
Prediction of STAS in lung adenocarcinoma with nodules ≤ 2 cm using machine learning: a multicenter retrospective study.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Ensemble machine learning classifiers based on computed tomography radiomics for predicting spread through air spaces in lung adenocarcinoma: a multicenter retrospective cohort study with transcriptomic interpretation.Quantitative imaging in medicine and surgery · 2026Article
- Development and validation of a radiomics-habitat model for preoperatively predicting poorly differentiated stage IA lung adenocarcinoma.Journal of thoracic disease · 2026Article
- Artificial intelligence in thoracic surgery: a narrative review of clinical advances and applications in 2025.Journal of thoracic disease · 2026Review
- Diffusion attention expert model for predicting and semi-automatic localizing STAS in lung cancer histopathological images.Nature communications · 2026Article
- Deep learning-based CT radiomics for ALK rearrangement status prediction in lung adenocarcinoma.BMC cancer · 2026Article
- Article
- Preoperative predictive factors and the prognostic impact of spread through air spaces in clinical stage IA lung adenocarcinoma.Surgery today · 2026Article
- Neutrophil Percentage-to-Albumin Ratio as a Novel Prognostic Biomarker in Adult Diffuse Gliomas: Retrospective Study Integrating 3 Machine Learning Models and Cox Regression.JMIR medical informatics · 2026Article
- A radiomics-based machine learning model and SHAP for predicting spread through air spaces and its prognostic implications in stage I lung adenocarcinoma: a multicenter cohort study.Cancer imaging : the official publication of the International Cancer Imaging Society · 2025Article
- Identification and verification of immune and oxidative stress-related diagnostic indicators for malignant lung nodules through WGCNA and machine learning.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
BACKGROUND AND
objectiveSpread through air spaces (STAS) is an important factor in determining the aggressiveness and recurrence risk of lung cancer, especially in early-stage adenocarcinoma. Preoperative identification of STAS is crucial for optimizing surgical strategies. This study aimed to develop and validate machine learning models to predict the presence of STAS using preoperative clinical, radiological, and pathological data in lung cancer patients. PATIENTS AND
methodsA retrospective analysis was conducted on 1,290 lung cancer patients from two hospitals: Qilu Hospital of Shandong University and Qianfoshan Hospital. Data from 1,174 patients from Qilu Hospital were used for model training and internal validation, while 116 patients from Qianfoshan Hospital were used for external validation. Thirteen key variables, identified using least absolute shrinkage and selection operator (LASSO) regression, were included in the construction of eight machine learning models: decision tree (DT), random forest (RF), regularized support vector machine (RSVM), logistic regression (LR), extreme gradient boosting (XGBoost), multilayer perceptron (MLP), light gradient boosting machine (LightGBM), and K-nearest neighbors (KNN). Model performance was evaluated using receiver operating characteristic (ROC) curves, area under the curve (AUC), calibration curves, decision curve analysis (DCA), and SHapley additive explanations (SHAP) plots.
resultsThe XGBoost model achieved the best performance with an AUC of 0.931 (95% CI: 0.897-0.964) in the internal validation cohort and 0.904 (95% CI: 0.835-0.973) in the external validation cohort, outperforming other models. DCA demonstrated the clinical utility of XGBoost, LightGBM, and RF models, which provided superior net benefit across various threshold probabilities. SHAP analysis revealed that the most influential factors in predicting STAS were carcinoembryonic antigen (CEA), forced expiratory volume in one second (FEV1), consolidation-to-tumor ratio (CTR), maximal voluntary ventilation (MVV), and CT value.
conclusionThe XGBoost model demonstrated robust predictive performance for preoperative identification of STAS in lung cancer patients, showing high generalizability in external validation. These findings suggest that machine learning-based predictions could guide clinical decision-making and improve surgical outcomes by identifying high-risk patients for more aggressive treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.